Results 161 to 170 of about 110,558 (326)

A search for Clostridium difficile ribotypes 027 and 078 in Brazil

Brazilian Journal of Infectious Diseases, 2014
Toxigenic strains of Clostridium difficile may be disseminating. Here we prospectively screened patients with nosocomial diarrhoea in two hospitals in Brazil. To identify C.
Alexandre de Almeida Monteiro, Renata Neto Pires, Søren Persson, Edison Moraes Rodrigues Filho, Alessandro Comarú Pasqualotto   +4 more
doaj  

Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions [PDF]

, 1982
W. Lance George, Rial D. Rolfe, S M Finegold   +2 more
openalex   +1 more source

The difficile in Clostridium difficile infection [PDF]

International Journal of Infectious Diseases, 2018
Garabet Akoghlanian, Seetha Lakshmi
openaire   +3 more sources

Enterocolitis associated with glofitamab—First report and clinicopathological findings in three cases

British Journal of Haematology, EarlyView.
Summary Glofitamab is a CD3‐CD20 bispecific antibody used to treat B‐cell non‐Hodgkin lymphoma. We describe three cases of enterocolitis occurring with glofitamab at a single institution. Similarities between cases include onset post cycle 4–5, moderately elevated faecal calprotectin, abnormal bowel avidity on positron emission tomography scan (2/3 ...
Sean McKeague, Molly Robertson, Sam van der Linde, Christine Khoo, Jonathan Segal, Sean Harrop, Adrian Minson, Andrew W. Roberts, Michael Dickinson   +8 more
wiley   +1 more source

Agent-Based Modeling of C. Difficile Spread in Hospitals: Assessing Contribution of High-Touch vs. Low-Touch Surfaces and Inoculations' Containment Impact [PDF]

arXiv
Health issues and pandemics remain paramount concerns in the contemporary era. Clostridioides Difficile Infection (CDI) stands out as a critical healthcare-associated infection with global implications. Effectively understanding the mechanisms of infection dissemination within healthcare units and hospitals is imperative to implement targeted ...
arxiv  

Isolation of Clostridium difficile from patients and the environment of hospital wards. [PDF]

, 1983
H Malamou-Ladas, S. O’Farrell, J Q Nash, S. Tabaqchali   +3 more
openalex   +1 more source

Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. [PDF]

, 1988
C Pothoulakis, R Sullivan, David Melnick, George Triadafilopoulos, A S Gadenne, Tova Meshulam, J. Thomas LaMont   +6 more
openalex   +1 more source

Clostridium difficile [PDF]

Journal of Medical Microbiology, 2005
openaire   +2 more sources

Clinical characteristics and treatment outcomes of linear IgA bullous dermatosis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Linear immunoglobulin A (IgA) bullous dermatosis (LABD), also referred to as chronic bullous disease of childhood (CBDC), is characterized by the linear deposition of IgA antibodies within the dermal‐epidermal junction. While dapsone is typically recommended, alternative modalities may be considered based on accessibility, severity, and prior ...
Kristie Mar, Fiona Landells, Bushra Khalid, Aswen Sriranganathan, Ou Jia Wang, Samantha Y. Starkey, Ivan V. Litvinov, Ilya Mukovozov   +7 more
wiley   +1 more source

Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study

Internal Medicine Journal, EarlyView.
Abstract Background Cystitis is a common infection in an otherwise healthy individual. Sulfonamide antibiotics are first‐line treatment options. Sulfonamide allergy label (SAL) is the second most common antibiotic allergy label in electronic health records, yet its impact on clinical outcomes in patients with cystitis is not well‐characterised.
Ray Moussa, Tyler Miluski, Gisoo Ghaffari, Taha Al‐Shaikhly   +3 more
wiley   +1 more source